Modulation of the Natural Killer Cell Compartment during DAAs treatment in Interferon-naïve HCV patients: The type of DAA matters

Immunol Lett. 2018 Nov:203:112-115. doi: 10.1016/j.imlet.2018.08.004. Epub 2018 Aug 23.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Hepacivirus / immunology*
  • Hepatitis C, Chronic* / drug therapy
  • Hepatitis C, Chronic* / immunology
  • Hepatitis C, Chronic* / pathology
  • Humans
  • Killer Cells, Natural / immunology*
  • Middle Aged

Substances

  • Antiviral Agents